INDAPTUS THERAPEUTICS INC (INDP)

US45339J1051 - Common Stock

0.8891  -0.05 (-5.21%)

After market: 0.91 +0.02 (+2.35%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/AN/A
183.65%		N/A
62.57%		N/A
58.47%
EBITDA
YoY % growth
-4.44M-5.18M
-16.67%		-6.85M
-32.24%		-13.14M
-91.82%		-28.61M
-117.73%		-42.47M
-48.44%		-32.6M
23.24%		-12.63M
61.26%		-7.73M
38.80%		-14.91M
-92.88%		-16.377M
-9.84%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-5.04M-5.77M
-14.48%		-7.6M
-31.72%		-13.84M
-82.11%		-29.44M
-112.72%		-43.33M
-47.18%		-33.45M
22.80%		-13.83M
58.65%		-7.73M
44.11%		-14.91M
-92.88%		-16.378M
-9.85%		N/A
-4.92%		N/A
-29.10%		N/A
-2.61%		N/A
-3.60%		N/A
139.80%		N/A
668.11%		N/A
86.42%		N/A
74.41%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/A-93.60
-20.11%		N/A
-7.23%		-112.00
-11.59%		-89.60
20.00%		-16.32
81.79%		-10.40
36.27%		-1.73
83.37%		-1.85
-6.94%		N/A
3.24%		N/A
38.18%		N/A
41.94%		N/A
-85.71%		N/A
135.90%		N/A
719.05%		N/A
86.63%		N/A
70.56%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.45
6.50%		-0.30
33.13%		-0.28
40.32%		-0.27
17.13%		-0.27
39.77%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.973M
-18.97%		-4.575M
-16.01%		-4.774M
-16.18%		-5.171M
-64.59%		-5.37M
-8.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.32
31.91%		-0.480.1633.25%
Q2 2024
Q2Q % growth		 -0.47
-20.51%		-0.550.0814.67%
Q1 2024
Q2Q % growth		 -0.45
11.76%		-0.580.1322.60%
Q4 2023
Q2Q % growth		 -0.48
-9.09%		-0.550.0712.85%
Q3 2023
Q2Q % growth		 -0.47
-11.90%		-0.560.0916.22%
Q2 2023
Q2Q % growth		 -0.39
15.22%		-0.590.2034.08%
Q1 2023
Q2Q % growth		 -0.51
-24.39%		-0.600.0915.25%
Q4 2022
Q2Q % growth		 -0.44
-100.00%		-0.530.0917.04%
Q3 2022
Q2Q % growth		 -0.42
48.15%		-0.540.1222.31%
Q2 2022
Q2Q % growth		 -0.46
91.68%		-0.490.036.05%
Q1 2022
Q2Q % growth		 -0.41
89.32%		-0.850.4451.57%
Q4 2021
Q2Q % growth		 -0.22
89.62%		-0.920.7076.03%
Q3 2021
Q2Q % growth		 -0.81
78.68%		-0.56-0.25-44.39%
Q2 2021
Q2Q % growth		 -5.53
-38.25%		-2.61-2.92-111.78%
Q1 2021
Q2Q % growth		 -3.84
40.00%		-3.55-0.29-8.18%
Q4 2020
Q2Q % growth		 -2.12
85.28%		-3.471.3538.87%
Q3 2020
Q2Q % growth		 -3.80
85.16%		-3.54-0.26-7.47%
Q2 2020
Q2Q % growth		 -4.00
83.33%		-4.350.358.08%
Q1 2020
Q2Q % growth		 -6.40
75.00%		-6.26-0.14-2.30%
Q4 2019
Q2Q % growth		 -14.40
51.35%		-12.24-2.16-17.65%
Q3 2019
Q2Q % growth		 -25.60
-14.29%		-17.75-7.85-44.24%
Q2 2019
Q2Q % growth		 -24.00
11.76%		-24.640.642.61%
Q1 2019
Q2Q % growth		 -25.60
21.95%		-29.994.3914.63%
Q4 2018
Q2Q % growth		 -29.60 -24.64-4.96-20.11%
Q3 2018
Q2Q % growth		 -22.40 -25.463.0612.02%
Q2 2018
Q2Q % growth		 -27.20 -26.60-0.60-2.25%
Q1 2018
Q2Q % growth		 -32.80 -23.12-9.68-41.87%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2019
Q2Q % growth		 765K-765K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -29.41% 11.14% 9.54%
RevenueN/A N/A N/A N/A